AXT, Inc. AXTI 深 沪
已收盘 02-06 16:00:00 美东时间
24.06
+3.630
+17.77%
华盛通- 最 高24.15
- 今 开21.41
- 成交量 698.39万股
- 最 低 20.82
- 昨 收 20.43
- 总市值 13.30亿
- 52周最高 26.66
- 市盈率 静 --
- 换手率 12.64%
- 52周最低 1.13
- 委 比 31.25%
- 总股本 5527.42万
- 历史最高 26.66
- 量 比 0.89
- 振 幅 16.30%
- 历史最低 1.13
- 每 手 1
- 风险率 6.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | 德克斯户外涨近20%，财报表现优异；磷化铟公司AXTI涨超13%
TechCreate Group Ltd. Class A涨100.1%；阿诺医药涨62.8%；罗致恒富涨27.8%
01-31 10:13
Charter Communications, Robert Half, Deckers Outdoor, Air Products And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling more than 300 points o...
01-31 00:15
Needham Downgrades AXT to Hold
Needham analyst Charles Shi downgrades AXT (NASDAQ:AXTI) from Buy to Hold.
01-20 19:20
美股牛股 | “八倍大牛股”High Roller再升25%！Figure大涨16%，推出链上公共股权网络
“八倍大牛股”High Roller再升25%！加密贷款机构Figure涨16%，推出链上公共股权网络；IBRX大涨逾30%，旗下创新药获批上市>>
01-16 15:44
Penumbra, ImmunityBio, Calix, Matson And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining more than 300 points ...
01-15 23:28
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
B. Riley Securities Downgrades AXT to Neutral, Raises Price Target to $18
B. Riley Securities analyst Dave Kang downgrades AXT (NASDAQ:AXTI) from Buy to Neutral and raises the price target from $9 to $18.
01-09 23:10
AXT shares are trading lower. The company updated its Q4 revenue expectations.
AXT shares are trading lower. The company updated its Q4 revenue expectations.
01-09 05:21
